SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-115093
Filing Date
2023-11-07
Accepted
2023-11-07 10:28:16
Documents
14
Period of Report
2023-11-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2330063d1_8k.htm   iXBRL 8-K 25549
2 EXHIBIT 99.1 tm2330063d1_ex99-1.htm EX-99.1 6797
6 GRAPHIC tm2330063d1_ex99-1img001.jpg GRAPHIC 11301
  Complete submission text file 0001104659-23-115093.txt   223800

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pahc-20231107.xsd EX-101.SCH 3003
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pahc-20231107_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pahc-20231107_pre.xml EX-101.PRE 22351
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2330063d1_8k_htm.xml XML 3383
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 231382238
SIC: 2834 Pharmaceutical Preparations